Commercial insight into the pharma and biotech sector.
Product Forecasts to 2016
- Intelligent consensus product forecasts to 2016 for high level market analysis
- Derived through a rigorous methodology to ensure accuracy – not via an automated process
- Forecasts updated with the latest market events
- Includes forecasts on Royalty, Joint Venture and Co-Promotion incomes
World Preview 2016 (June 2011)
This new edition of World Preview 2016 , published June 2011, once again brings together many of our analyses to provide a top level insight, from the world’s financial markets, into the expected performance of the industry between now and 2016. The report offers an updated analysis of the market focusing on the changes in 2016 forecasts since last year's World Preview 2016 published May 2010.
Based on EvaluatePharma's comprehensive coverage of the world's leading pharmaceutical and biotech companies, World Preview 2016 highlights trends in prescription drugs sales, patent risk, R&D spend, global brand sales and therapeutic performance plus a brief review of 2010 performance.
Register to download World Preview 2016 (June 2011) and for access to a selection of free analysis and insights